QVIDTVM Management LLC 13F Portfolio

CIK 1912226 Filing since Q4 2021 Q2 2026 filed Aug 13, 2026
Holdings as of Jun 30, 2026, from the 13F filed Aug 13, 2026.

Portfolio Snapshot

14 positions · Q2 2026

QVIDTVM Management LLC reported 14 positions worth $76.60M for the quarter ended Jun 30, 2026, down 5.9% on the prior quarter. It opened 1 new position, added to 3, trimmed 10 and exited 1. Its largest holding is Bio-Rad Laboratories, Inc. at 25.4% of the portfolio.

Portfolio Value
$76.60M
-5.9% QoQ · -23.3% YoY
Positions
14
1 new · 1 sold out
Top 10 Concentration
99.2%
of portfolio value
Largest Position
BIO 25.4%
Bio-Rad Laboratories, Inc.
Net Buying
-$21.58M
$7.42M bought · $29.01M sold
Turnover
9.4%
of the portfolio traded
Top Sector
Healthcare
34.9% of value
Track Record
19
quarters on file since Q4 2021

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

7 sectors
34.86%
Healthcare
Healthcare34.86%
Technology29.66%
Basic Materials17.21%
Consumer Discretionary7.75%
Real Estate5.69%
Consumer Staples4.52%
Industrials0.306%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

HealthcareTechnologyBasic MaterialsConsumer DiscretionaryReal EstateConsumer StaplesIndustrialsFinancial ServicesCommunication ServicesOther

Largest Buys

Q2 2026
Holding Change Change % Trade Value Weight
ORCL Oracle Corp +18.1K +46.4% $2.65M 10.9%
ARE Alexandria Real Estate Equities, Inc. +42.5K +106.2% $2.24M 5.69%
AMRZ Amrize Ltd +29.9K +13.8% $1.60M 17.21%
OCTV Octave Intelligence plc +57.5K – $936.70K 1.22%

Largest Sells

Q2 2026
Holding Change Change % Trade Value Weight
SOLV Solventum Corp -176.6K -66.5% $13.62M 8.97%
BIO Bio-Rad Laboratories, Inc. -17.5K -20.9% $5.13M 25.39%
XRAY DENTSPLY SIRONA Inc. -366.5K -95.1% $3.89M 0.262%
NBIS Nebius Group N.V. -12.0K -19.8% $3.32M 17.54%
ZGN Ermenegildo Zegna N.V. -70.1K -13.3% $912.56K 7.75%
HRB H&R Block Inc -22.4K -96.4% $853.42K 0.042%
WAB Westinghouse Air Brake Technologies Corp -2,020 -72.9% $544.59K 0.264%
BRCC BRC Inc. -44.8K -13.2% $496.77K 4.28%
RTO Rentokil Initial Plc -6,879 -100.0% $216.55K Exited
PM Philip Morris International Inc. -53 -4.9% $9.59K 0.242%

New Positions

Q2 2026
Holding Shares Trade Value Weight
OCTV Octave Intelligence plc +57.5K $936.70K 1.22%

Closed Positions

Q2 2026
Holding Shares Sold Trade Value Prior Weight
RTO Rentokil Initial Plc -6,879 $216.55K 0.266%
Holdings · Q2 2026

14 Positions

As ofJun 30, 2026
Value$76.60M
Top 1099.2%
Avg position$5.47M
# Activity
Showing all 14 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at QVIDTVM Management.

About QVIDTVM Management LLC’s 13F Portfolio

What are QVIDTVM Management LLC’s largest holdings?

As of its Q2 2026 13F filing, QVIDTVM Management LLC’s five largest positions were Bio-Rad Laboratories, Inc. (BIO) at 25.4%, Nebius Group N.V. (NBIS) at 17.5%, Amrize Ltd (AMRZ) at 17.2%, Oracle Corp (ORCL) at 10.9%, Solventum Corp (SOLV) at 9.0% of the reported portfolio.

How much is QVIDTVM Management LLC’s portfolio worth?

QVIDTVM Management LLC reported a 13F portfolio worth $76.60M across 14 positions for Q2 2026. That is down 5.9% from the previous quarter.

What did QVIDTVM Management LLC buy in Q2 2026?

Its largest purchases by value were Oracle Corp ($2.65M), Alexandria Real Estate Equities, Inc. ($2.24M), Amrize Ltd ($1.60M). It opened 1 new positions.

What did QVIDTVM Management LLC sell in Q2 2026?

Its largest sales by value were Solventum Corp ($13.62M), Bio-Rad Laboratories, Inc. ($5.13M), DENTSPLY SIRONA Inc. ($3.89M). It exited 1 positions entirely.

Where does this data come from?

From the Form 13F-HR reports QVIDTVM Management LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.